New diabetes drug safety check underway in pakistan
Disease control
Recruiting now
This study is checking how safe and well-tolerated the diabetes drug empagliflozin (taken with or without metformin) is in Pakistani adults with type 2 diabetes. About 2000 people aged 18-65 with poorly controlled blood sugar will be followed for 6 months. The study will track si…
Phase: PHASE4 • Sponsor: Getz Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC